- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03398096
Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study
January 7, 2018 updated by: Ya-Wei Xu, Shanghai 10th People's Hospital
Cardiac shock wave therapy (CSWT) is a noninvasive new therapeutic option in the treatment of chronic refractory angina pectoris.
Many domestic and international researches have revealed that CSWT contributes to revascularization by stimulating angiogenesis.
We were aimed to evaluate the safety and efficiency of CSWT in the treatment of refractory angina.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Weijing Liu
- Phone Number: 18917684041
- Email: liuweijing98@sina.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200072
- Shanghai Tenth People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients were 18 to 80 years old;
- Coronary angiography (CA) or multi-slice CT coronary angiography (CTCA) suggestive of moderate to severe coronary artery stenosis;
- Chest tightness, onset of shortness of breath, and poor exercise tolerance after receiving formal drug treatment (with or without stent or bypass graft);
- Hospitalized more than 2 times within 1 year due to the aforementioned problems;
- CCS angina grading higher than grade II, and New York Heart Association (NYHA) class I-III;
- More than 1 month after acute myocardial infarction (AMI) and 1 month after percutaneous coronary intervention (PCI) surgery.
Exclusion Criteria:
- AMI、PCI or coronary artery bypass graft (CABG) within the 4 weeks prior to the study;
- History of heart transplantation;
- History of metal valve replacement surgery;
- Intra-cardiac thrombus;
- Left Ventricular Ejection Fraction (LVEF) < 30 % and unstable hemodynamics;
- Arrhythmia with a rate < 40 bpm or > 120 bpm;
- Skin ulceration or infection in the treatment area;
- Severe obstructive lung disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cardiac shock wave therapy (CSWT) group
The CWST group were performed with a CSWT equipment (Storz Medical, Switzerland) followed the recommended protocol developed by Tohoku University of Japan with respect to the shockwave output and the number of shots implemented to each spot and the protocol developed by the University of Essen, Germany.
|
Ultrasound guided cardiac shock wave therapy (CSWT) is a new treatment method offering an alternative to revascularization by stimulating angiogenesis.
Subsequent clinical trials showed that CSWT could reduce symptoms of myocardial ischemia and improve cardiac function in patients with severe coronary artery disease.
|
No Intervention: Control group
No CWST treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Canadian Cardiovascular Society (CCS) grading of angina
Time Frame: 6 months
|
questionnaire of Canadian Cardiovascular Society grading of angina concerning exercise tolerance
|
6 months
|
Seattle angina questions (SAQ)
Time Frame: 6 months
|
questionnaire of Seattle angina questions to evaluate the effect of coronary artery disease on patients' life quality
|
6 months
|
6-min walk test
Time Frame: 6 months
|
All participants will receive a 6 minutes' walk test to evaluate their effect of treatment of cardiac shock wave therapy
|
6 months
|
Nitrate consumption
Time Frame: 6 months
|
All participants will receive a questionnaire of the amount of nitrate they need before and after treatment of cardiac shock wave therapy
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 30, 2018
Primary Completion (Anticipated)
June 30, 2018
Study Completion (Anticipated)
September 30, 2018
Study Registration Dates
First Submitted
December 14, 2017
First Submitted That Met QC Criteria
January 7, 2018
First Posted (Actual)
January 12, 2018
Study Record Updates
Last Update Posted (Actual)
January 12, 2018
Last Update Submitted That Met QC Criteria
January 7, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSWT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Cardiac shock wave therapy
-
Ya-Wei XuScience and Technology Commission of Shanghai MunicipalityRecruitingMyocardial Infarction With Non-obstructive Coronary Arteries | Cardiac Shock Wave TherapyChina
-
Beijing HospitalRecruitingCoronary Artery DiseaseChina
-
Beijing HospitalCompleted
-
Kunming Medical UniversityCompletedCoronary Artery DiseaseChina
-
Rodrigo Marcel Valentim da SilvaUniversidade Federal do Rio Grande do NorteCompletedPain | Muscle Tonus
-
Northern Orthopaedic Division, DenmarkCompletedChronic Inflammatory Disorder
-
The First Affiliated Hospital of Kunming Medical...Not yet recruitingST Elevation Myocardial Infarction | Myocardial Reperfusion Injury | Prognosis | Treatment Outcome
-
Yuzuncu Yıl UniversityCompleted
-
Isfahan University of Medical SciencesUnknownPlantar FasciitisIran, Islamic Republic of
-
Yonsei UniversityUnknownPost-Stroke Elbow SpasticityKorea, Republic of